Vanda Pharmaceuticals, Inc. (VNDA)

8.82 +1.79 (+25.46%) USD  |  NASDAQ  |  Dec 31, 16:00
8.805 -0.02 (-0.17%) Pre-Market: 08:22
More

Vanda Pharmaceuticals Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for VNDA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Exelixis, Inc. Upgrade
AnaptysBio, Inc. Upgrade